Morning Headlines 12/27/24
A CNBC analysis of 39 publicly traded digital health companies finds that two-thirds lost value in 2024 ,with high-profile stumbles by Teladoc Health, Progyny, GoodRx, Dexcom, and 23andMe.
Researchers find that CMS’s four-year-old program that encourages a home alternative to hospital admission will need to offer different incentives to expand to smaller, rural, and non-teaching hospitals.
Providers Used Medicare Part D Eligibility Verification Transactions for Permissible Purposes
An HHS OIG investigation finds minimal improper use of Medicare Part D prescription eligibility transactions by providers after CMS tightened controls.
Telemedicine provider Avel ECare acquires Hospital Pharmacy Management, which offers remote pharmacy order verification and hospital pharmacy management.
I can't get past the helmets and safety vests. On everyone. Including the model patient. What, are they expecting the…